EXEL
EXELIXIS, INC.
Latest Form 4:Sale$527KbyBeckerle Mary C (Director) · filed Aug 12, 2026
EXELIXIS, INC. (EXEL) has 53 SEC Form 4 filings (92 transaction rows) in the rolling window, disclosed by 13 distinct insiders. Most recent filing: Aug 12, 2026.
The most active filer is EVP, Research and Development Aftab Dana with 4 filings. Insiders have net sold $31.8M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Michael Morrissey
- Employees:1,147
- HQ:Alameda, CA, US
- IPO:2000-04-17
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$42.2M
reported sales (SEC code S)
Unique Insiders
13
in the rolling window
Market Cap
$13.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Beckerle Mary CFirst in 3 months | Director | Sale | 9,812 | $527K | Aug 12 | SEC ↗ |
WYSZOMIERSKI JACK LFirst in 3 months | Director | Sale | 3,925 | $198K | Jun 3 | SEC ↗ |
Eckhardt Sue GailFirst in 4 months | Director | Sale | 9,812 | $492K | Jun 3 | SEC ↗ |
Aftab DanaFirst in 3 months | EVP, Research and Development | Sale | 43,451 | $2.2M | May 28 | SEC ↗ |
Haley Patrick J.First in 3 months | EVP, Commercial | Sale | 32,110 | $1.6M | May 22 | SEC ↗ |
Senner Christopher J.First in 3 months | EVP and CFO | Sale | 34,901 | $1.7M | May 19 | SEC ↗ |
Hefti BrendaFirst in 3 months | SVP and General Counsel | Sale | 6,625 | $333K | May 19 | SEC ↗ |
Beckerle Mary CFirst in 6 months | Director | Sale | 7,712 | $374K | May 8 | SEC ↗ |
Freire Maria CFirst filing | Director | Sale | 20,634 | $949K | May 8 | SEC ↗ |
POSTE GEORGEFirst filing | Director | Sale | 60,000 | $2.7M | May 8 | SEC ↗ |
| EVP, Research and Development | Sale | 47,918 | $2.1M | Feb 26 | SEC ↗ | |
Aftab DanaFirst in 3 months | EVP, Research and Development | Sale | 29,873 | $1.3M | Feb 23 | SEC ↗ |
WYSZOMIERSKI JACK LFirst filing | Director | Sale | 99,574 | $4.4M | Feb 20 | SEC ↗ |
Smith JulieFirst filing | Director | Sale | 42,422 | $1.8M | Feb 19 | SEC ↗ |
Smith JulieFirst filing | Director | Sale | 64,117 | $2.8M | Feb 19 | SEC ↗ |
Senner Christopher J.First filing | EVP and CFO | Sale | 34,278 | $1.5M | Feb 18 | SEC ↗ |
Senner Christopher J.First filing | EVP and CFO | Sale | 30,617 | $1.3M | Feb 18 | SEC ↗ |
| EVP, Commercial | Sale | 67,814 | $3.0M | Feb 18 | SEC ↗ | |
Oliver BobFirst filing | Director | Sale | 30,250 | $1.3M | Feb 18 | SEC ↗ |
Hefti BrendaFirst filing | SVP and General Counsel | Sale | 18,669 | $822K | Feb 18 | SEC ↗ |
Eckhardt Sue GailFirst filing | Director | Sale | 3,856 | $169K | Feb 18 | SEC ↗ |
JOHNSON DAVID EDWARDFirst filing | Director | Purchase | 27,532 | $1.2M | Nov 26 | SEC ↗ |
Haley Patrick J.First filing | EVP, Commercial | Sale | 44,187 | $1.9M | Nov 24 | SEC ↗ |
Haley Patrick J.First filing | EVP, Commercial | Sale | 28,043 | $1.2M | Nov 24 | SEC ↗ |
Beckerle Mary CFirst filing | Director | Sale | 24,622 | $1.0M | Nov 13 | SEC ↗ |
PAPADOPOULOS STELIOSFirst filing | Director | Sale | 100,000 | $4.4M | Nov 13 | SEC ↗ |
Aftab DanaFirst filing | EVP, Research and Development | Sale | 48,383 | $2.1M | Nov 13 | SEC ↗ |
Related companies
EXELIXIS, INC. is in the Healthcare sector.